pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,939 catalysts · 5,063 phase readout · 2,308 8k filing · 316 pdufa · 271 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,063
  • 8k filing2,308
  • pdufa316
  • earnings271
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area
    • Oncology87
    • Cardiology23
    • Immunology15
    • Infectious Disease12
    • Dermatology12
    • Ophthalmology8
    • Women's Health8
    • Pulmonology8
    • Pain6

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07472387: Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Glioblastoma (GBM)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06704893: Amniotic Suspension Allograft Injection for Knee Osteoarthritis

    Sponsor: Chang Gung Memorial Hospital. Phase: PHASE3. Conditions: Knee, Osteoarthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07408921: Effect of Ice Pack and Warm Gel Pad Use During Drain Removal on Anxiety, Comfort, Physiological Parameters, and Patient Satisfaction Undergoing Open Urological Surgery

    Sponsor: Tarsus University. Phase: NA. Conditions: Drain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05789316: Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)Washington University School of Medicine

    Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Head and Neck Cancer Survivors, Cancer of the Head and Neck Surviors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06616584: Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)REGENERON PHARMACEUTICALS, INC.

    Sponsor: SWOG Cancer Research Network. Phase: PHASE2. Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05685433: A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

    Sponsor: Valencia Technologies Corporation. Phase: NA. Conditions: Overactive Bladder, Urge Incontinence, Incontinence, Urinary, Urinary Urge Incontinence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07455552: Comparison of Telemedicine-based and Home-based Inspiratory Muscle Training After Lung Resection in High-risk Patients

    Sponsor: Pusan National University Hospital. Phase: NA. Conditions: Pulmonary Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04323449: Evaluation of Vision-Guided Shared Control for Assistive Robotics Manipulators

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Spinal Cord Injury/Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06436638: Comparison of Nasal Continuous Positive Airway Pressure (CPAP) Mask and Nasal Airway in Molar Tooth Extraction Under Deep Sedation

    Sponsor: Gözde Nur Erkan. Phase: . Conditions: Deep Sedation, Non-invasive Ventilation Support, Nasal Airway, Nasal CPAP Mask, Impacted Molar

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05722938: Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

    Sponsor: Biotest. Phase: PHASE3. Conditions: Community-acquired Pneumonia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06265558: Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery

    Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06681558: Procedural Oxygen Mask vs. Nasal Cannula for Hypoxemia Prevention During Endoscopic Retrograde Cholangiopancreatography

    Sponsor: Kocaeli City Hospital. Phase: NA. Conditions: Hypoxemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05448755: A Study of ELX-02 in Patients With Alport SyndromeEloxx Pharmaceuticals, Inc.

    Sponsor: Eloxx Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Alport Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07512726: DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer

    Sponsor: Ilknur Yazicioglu. Phase: NA. Conditions: Colorectal Cancer, Colorectal (Colon or Rectal) Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06435026: Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1

    Sponsor: University of North Carolina, Chapel Hill. Phase: PHASE2. Conditions: HIV, Prevention, Pregnancy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07419126: Ultrasound Assessment of Arterial Medial Calcification in Endurance Athletes: A Prevalence Study

    Sponsor: University Hospital, Grenoble. Phase: . Conditions: Calcifications, Vascular

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07414485: Evaluation and Validation of an Algorithm for Predicting Delayed Conduction Disorders After TAVR: a Multicentre Observational Study

    Sponsor: University Hospital, Montpellier. Phase: . Conditions: Delayed High-grade Conduction Disturbances After Transcatheter Aortic Valve Implantation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05137925: Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum

    Sponsor: University of Pittsburgh. Phase: NA. Conditions: Psychological Distress, Pregnancy Related, Postpartum Blues, Postpartum Depression, Postpartum Anxiety, Postpartum Sadness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06064825: Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT)IGC Pharma, Inc.

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07160725: A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid TumorsBristol-Myers Squibb Co

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Solid Tumours

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05988892: A Study of Physical Activity in Cancer SurvivorsMayo Clinic

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Cancer, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06827236: A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerBioNTech SE

    Sponsor: BioNTech SE. Phase: PHASE1. Conditions: Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04239144: Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas DiseaseUniversity of Sao Paulo General Hospital

    Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Chagas Cardiomyopathy, Ventricular Arrythmia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06627764: SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant FamiliesDuke University

    Sponsor: Duke University. Phase: NA. Conditions: Substance Abuse, Intimate Partner Violence (IPV), HIV Infections, Depression, Anxiety

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06903364: Association of Lifestyle With Complications in the Diabetic Population

    Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Diabetes Mellitus

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07534709: Suzetrigine for Opioid-Free Recovery After Cesarean DeliveryVertex, Inc.

    Sponsor: University of Texas at Austin. Phase: PHASE4. Conditions: Cesarean Delivery, Cesarean Section, Pain, Postoperative, Opioid Consumption, Postoperative

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT03604991: Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07528274: Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

    Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: NSCLC (Non-small Cell Lung Cancer), NSCLC (Advanced Non-small Cell Lung Cancer)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06865482: Clinical Course Of Disease In Participants With FA-CM

    Sponsor: Lexeo Therapeutics. Phase: . Conditions: Friedreich Ataxia, Cardiomyopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07504224: ASD Wearables Feasibility Study

    Sponsor: Rady Pediatric Genomics & Systems Medicine Institute. Phase: NA. Conditions: Autism Spectrum Disorder, Wearable Devices

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05597124: Exercise to Improve Brain Health in Older African Americans

    Sponsor: Rutgers, The State University of New Jersey. Phase: PHASE2. Conditions: Aging, Alzheimer Disease, Healthy Aging, Cognitive Change

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07353723: Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

    Sponsor: Tang-Du Hospital. Phase: PHASE2. Conditions: Head & Neck Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07118124: Pediatric Adhesion and New Dermal Approach Study

    Sponsor: iRhythm Technologies, Inc.. Phase: NA. Conditions: Syncope, Pediatric, Congenital Athymia, Congenital Heart Disease, Arrhythmia, Arrhythmia in Children

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00250159: Natural History Study of Patients With Excess Androgen

    Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Congenital Adrenal Hyperplasia (CAH), Familial Male-Limited Precocious Puberty (FMPP)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04661280: Donepezil Versus Non-drug Treatment in Alzheimer's Disease.

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Alzheimer Disease, Early Onset

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06972979: Investigation of a Patient Support Intervention for Statin Medication Adherence

    Sponsor: Ascension Health. Phase: NA. Conditions: Medication Adherence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07512596: Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

    Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE2. Conditions: Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07232862: Analysis Of The Effect Of A Fine Manual Skills Intervention In A Specific Context On The Linguistic Processing of Healthy Young Adults

    Sponsor: Federal University of Health Science of Porto Alegre. Phase: NA. Conditions: Healthy Participants

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05396846: My Best GI Eating Study

    Sponsor: University of Michigan. Phase: NA. Conditions: Colorectal Neoplasms

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07418827: Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project

    Sponsor: Assistance Publique Hopitaux De Marseille. Phase: . Conditions: Haemophilia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05703269: Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: NSCLC, Renal Cell Carcinoma, Breast Carcinoma, Melanoma, Brain Metastases, Adult, Non-small Cell Lung Cancer, SCLC, Small-cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03218969: Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist

    Sponsor: William Ondo, MD. Phase: PHASE1. Conditions: Restless Legs Syndrome, Augmentation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05226169: Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

    Sponsor: Asan Medical Center. Phase: PHASE3. Conditions: Advanced Gastric Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04762069: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

    Sponsor: CNS Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Glioblastoma Multiforme, Adult

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02064569: Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients

    Sponsor: GenSight Biologics. Phase: PHASE1. Conditions: Leber Hereditary Optic Neuropathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01413269: Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE3. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02784769: Matrix Aging and Aneurysm

    Sponsor: CHU de Reims. Phase: NA. Conditions: Aortic Aneurysm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06994169: Glofitamab in Real Life

    Sponsor: The Lymphoma Academic Research Organisation. Phase: . Conditions: Large B-cell Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07516041: Metaverse- and VR-Supported Education in a Digital Breastfeeding Museum: Long-Term Effects on Breastfeeding Process, Self-Efficacy, and Motivation

    Sponsor: Uludag University. Phase: NA. Conditions: Metaverse, Virtual Reality, Digital Museum, Breastfeeding Education, Breastfeeding Self-Efficacy, Breastfeeding Duration, Breastfeeding Motivation, Breastfeeding Problems Assessment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03507205: Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents

    Sponsor: Seoul National University Hospital. Phase: . Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ← prev
    page 60 of 159
    next →
    $IGC0.2670+0.41%
    $BNTX92.45+1.49%
    $VERX13.24+4.75%
    $REGN695.18+4.20%
    $ELOX